This is a recording of a live webinar that took place on Wednesday 25 March 2026. This recording will be available to view until 10 December 2026.
Biological medicines are complex medicines made or derived from a biological source. A biosimilar medicine (known as a ‘biosimilar’) contains a version of an active substance of an approved biological medicinal product, known as the reference product. Biological medicines are used to treat many conditions including cancers, diabetes, arthritis, psoriasis, neutropenia and enzyme or hormone deficiencies (NHS England, 2023).
Biologic medications are increasingly being used to treat a range of conditions in secondary care, and there is a growing number of biosimilars in use. Primary care rarely gets involved in their use, however with the shift from hospital to community care as part of the NHS 10-Year Health Plan, this webinar will focus on what biosimilars are, their development, and how we can consider the shift to their use in the community.
Webinar Chair:
Dr Kevin Barrett MRCGP, GP New Road Surgery Croxley Green, Divisional Medical Director for Hertfordshire and Deputy Caldicott Guardian CLCH
Webinar speakers:
Dr Marion Sloan, GP & Chair of the Primary Care Society for Gastroenterology, PCSG
Sherwin Criseno, Advanced Nurse Practitioner in Endocrinology
Philip Newland-Jones, Consultant Pharmacist and Honorary Associate Professor in Diabetes and Endocrinology at the University of Southampton
Funded by:
This webinar was funded by Sandoz UK. Sandoz were asked to suggest speakers and topics however, full editorial control remains the sole responsibility of the RCGP.
